- Report
- March 2024
- 184 Pages
Global
From €3277EUR$3,374USD£2,800GBP
€3641EUR$3,749USD£3,111GBP
- Report
- May 2024
- 182 Pages
Global
From €5293EUR$5,450USD£4,522GBP
- Report
- March 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,149GBP
- Report
- November 2023
- 100 Pages
Global
From €2865EUR$2,950USD£2,448GBP
- Report
- October 2023
- 177 Pages
Global
From €4808EUR$4,950USD£4,107GBP
- Report
- November 2023
- 172 Pages
North America
From €1457EUR$1,500USD£1,245GBP
- Report
- June 2021
- 100 Pages
Global
From €5779EUR$5,950USD£4,937GBP
- Report
- July 2022
- 100 Pages
Global
From €2671EUR$2,750USD£2,282GBP
- Report
- May 2022
- 120 Pages
Global
From €2428EUR$2,500USD£2,074GBP
- Report
- January 2020
- 129 Pages
Asia Pacific
From €2040EUR$2,100USD£1,742GBP
€2914EUR$3,000USD£2,489GBP
- Report
- January 2020
- 130 Pages
North America
From €2040EUR$2,100USD£1,742GBP
€2914EUR$3,000USD£2,489GBP
- Report
- January 2020
- 139 Pages
Europe
From €2040EUR$2,100USD£1,742GBP
€2914EUR$3,000USD£2,489GBP
- Report
- December 2019
- 152 Pages
Global
From €3093EUR$3,185USD£2,643GBP
€4419EUR$4,550USD£3,775GBP
- Report
- June 2022
- 110 Pages
Global
From €4613EUR$4,750USD£3,941GBP
- Report
- June 2021
- 175 Pages
Global
From €3496EUR$3,600USD£2,987GBP
- Report
- June 2021
- 73 Pages
Europe
From €1457EUR$1,500USD£1,245GBP
- Report
- June 2021
- 75 Pages
Asia Pacific
From €1457EUR$1,500USD£1,245GBP
- Report
- June 2021
- 65 Pages
North America
From €1457EUR$1,500USD£1,245GBP
- Report
- June 2021
- 73 Pages
Middle East, Africa
From €1457EUR$1,500USD£1,245GBP
The High Flow Nasal Cannula (HFNC) is a respiratory device used to deliver humidified oxygen or air to a patient. It is a non-invasive form of respiratory support that is used to treat patients with respiratory distress. The device consists of a nasal cannula connected to a flow generator, which is used to regulate the flow of oxygen or air. The device is designed to provide a higher flow rate than traditional nasal cannulas, allowing for improved oxygen delivery and improved patient comfort.
HFNC is used in a variety of clinical settings, including emergency departments, intensive care units, and home care settings. It is used to treat a variety of respiratory conditions, including chronic obstructive pulmonary disease, asthma, and acute respiratory distress syndrome.
The HFNC market is a rapidly growing segment of the respiratory device market. It is expected to continue to grow as more healthcare providers recognize the benefits of HFNC in treating respiratory conditions.
Some companies in the HFNC market include Fisher & Paykel Healthcare, Philips Respironics, Vapotherm, and ResMed. Show Less Read more